Oral microbiota and neuroinflammation in pathogenesis of parkinson’s desease
Keywords:
parkinson's disease, neuroinflammation, neurodegenerationoral, microbiome, oral microbiota, oral dysbiosis, periodontitis, periodontal pathogens, porphyromonas gingivalis, alpha-synuclein, oral-gut-brain axis, microglia activationAbstract
Oral Microbiota and Neuroinflammation in the Pathogenesis of Parkinson’s Disease Abstract: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by α-synuclein aggregation and chronic neuroinflammation. Emerging evidence suggests that oral microbiota dysbiosis, particularly the proliferation of periodontal pathogens like Porphyromonas gingivalis, plays a significant role in PD pathogenesis through the "oral-gut-brain" axis. This literature review systematically analyzes the mechanisms by which oral pathobionts and their virulence factors (such as lipopolysaccharides and gingipains) disrupt mucosal barriers, induce systemic inflammation, and trigger microglial activation in the central nervous system. Furthermore, we discuss the clinical correlations between periodontal disease and PD severity, highlighting the potential of salivary biomarkers for early, non-invasive diagnosis. Ultimately, the review explores microbiome-targeted therapeutic strategies, emphasizing that maintaining periodontal health may mitigate neuroinflammation and potentially slow disease progression.